Vitaspring Biomedical (VSBC) Return on Assets [ROA] (2018 - 2026)
Vitaspring Biomedical's Return on Assets [ROA] came in at -3471.04% for fiscal Q2 2027 (quarter ended Jul 31, 2026), up 198.36 percentage points from -3669.40% a year earlier but down 325.10 percentage points from the prior quarter.
Powered by 
Analysis
Vitaspring Biomedical (VSBC) Return on Assets [ROA] (2018 - 2026) Analysis & Trends
For FY2026 (ended Jan 31, 2026), Vitaspring Biomedical's Return on Assets [ROA] was -2859.28%, down 1837.77 percentage points from FY2025.
- Return on Assets [ROA] has declined in each of the last four fiscal years, with a five-year change of -2410.09 percentage points (FY2021 to FY2026).
- Going back by fiscal year, Return on Assets [ROA] was -1021.52% in FY2025 (-773.85 pp), -247.66% in FY2024 (-244.11 pp), -3.55% in FY2023 (-51.50 pp) and 47.95% in FY2022 (+497.15 pp).
- The five-year range for quarterly Return on Assets [ROA] is -4858.36% (fiscal Q1 2026) to 56.68% (fiscal Q4 2022).
- Year-over-year, Return on Assets [ROA] increased in three of the last eight quarters, with an average year-over-year change of -1053.77 percentage points.
- The fastest year-over-year change in Return on Assets [ROA] over five years came in fiscal Q1 2027 (a gain of 1712.42 percentage points), and the weakest in fiscal Q1 2026 (a drop of 4090.92 percentage points).
- Business Quant data shows VSBC's Return on Assets [ROA] at -3145.94% (Q1 2027), -2667.66% (Q4 2026) and -2849.28% (Q3 2026) in the three fiscal quarters before Q2 2027.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | ROA (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,348.13 Bn | 1,321.74 Bn | 20.46 Bn | 19.00% |
| 2 | Johnson & Johnson | 675.90 Bn | 595.76 Bn | 17.30 Bn | 8.08% |
| 3 | AbbVie | 519.45 Bn | 487.50 Bn | 13.12 Bn | 7.32% |
| 4 | Merck | 364.95 Bn | 327.95 Bn | 13.19 Bn | 1.87% |
| 5 | Novartis Ag | 311.58 Bn | 285.16 Bn | - | - |
| 6 | Astrazeneca | 289.34 Bn | 262.94 Bn | 13.26 Bn | 9.36% |
| 7 | Amgen | 251.64 Bn | 203.30 Bn | 7.58 Bn | 9.80% |
| 8 | Gilead Sciences | 212.05 Bn | 187.07 Bn | 6.73 Bn | -7.67% |
| 9 | Pfizer | 167.35 Bn | 115.00 Bn | 12.56 Bn | 2.00% |
| 10 | Vitaspring Biomedical | 4.14 Mn | 4.12 Mn | - | -3,471.04% |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jul 31, 2026 | -3,471.04% |
| Apr 30, 2026 | -3,145.94% |
| Jan 31, 2026 | -2,667.66% |
| Oct 31, 2025 | -2,849.28% |
| Jul 31, 2025 | -3,669.40% |
| Apr 30, 2025 | -4,858.36% |
| Jan 31, 2025 | -2,130.08% |
| Oct 31, 2024 | -1,397.02% |
| Jul 31, 2024 | -915.92% |
| Apr 30, 2024 | -767.44% |
| Jan 31, 2024 | -539.47% |
| Oct 31, 2023 | -282.87% |
| Jul 31, 2023 | -182.07% |
| Apr 30, 2023 | -100.20% |
| Jan 31, 2023 | -4.82% |
| Oct 31, 2022 | 37.23% |
| Jul 31, 2022 | 35.46% |
| Apr 30, 2022 | 42.26% |
| Jan 31, 2022 | 44.43% |
| Oct 31, 2021 | -33.84% |
API Access
Vitaspring Biomedical Return on Assets [ROA] API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=return-on-assets-%5Broa%5D&ticker=VSBC&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "return-on-assets-[roa]", "ticker": "VSBC", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=return-on-assets-%5Broa%5D&ticker=VSBC&period=max&api_key=YOUR_API_KEY");
const data = await res.json();